Skip to main content
Clinical Trials/NCT05924126
NCT05924126
Recruiting
N/A

Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit: Appropriateness and Therapeutic Outcomes

Meir Medical Center1 site in 1 country155 target enrollmentJanuary 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Septic Patients Admitted to the ICU
Sponsor
Meir Medical Center
Enrollment
155
Locations
1
Primary Endpoint
Proportion of septic patients who recieved inappropriate empiric antibiotic therapy
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

Sepsis is one of the most common causes of ICU admission. About 5-15% of patients admitted to the hospital with an infection will have sepsis, and about 30-40% of them will have septic shock. About 34% of septic patients and about 53% of patients with septic shock will die within 28 days of admission. Broad-spectrum empiric antibiotic treatment (depending on the source of infection and patient risk factors) is one of the cornerstones of sepsis management. According to the recommendations of the surviving sepsis campaign, empiric antibiotic treatment should be given within one hour of the patient's arrival for patients with sepsis or septic shock. Administration of inappropriate antibiotics in the first 24 hours of admission was found in 34% of septic patients in various studies, and administration of inappropriate antibiotics (or when administered in delay) was found to be associated with increased morbidity and mortality.

In this study, we will assess the proportion of patients who were admitted to the ICU due to sepsis or septic shock and received empiric antibiotic treatment which, in retrospect, according to the growth in the cultures later on, was inappropriate. We will also assess the therapeutic results in these patients - mainly significant morbidity and mortality within 28 days, and compare them to the group of patients who received appropriate antibiotic therapy. We would also like to assess what were the possible reasons for inappropriate empiric antibiotic treatment, in order to draw conclusions to reduce the rate of these cases.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
September 2025
Last Updated
11 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

sara dichtwald

Dr

Meir Medical Center

Eligibility Criteria

Inclusion Criteria

  • All patients admitted to the general ICU due to sepsis or septic shock between 1/1/20 and 31/12/20

Exclusion Criteria

  • Patients who were admitted due to other non-infectious etiologies

Outcomes

Primary Outcomes

Proportion of septic patients who recieved inappropriate empiric antibiotic therapy

Time Frame: January 2020-December 2020

Proportion of septic patients who recieved inappropriate empiric antibiotic therapy

Study Sites (1)

Loading locations...

Similar Trials